Trial
NCT01408160
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Albert Einstein College of Medicine
Collaborators
National Cancer Institute (NCI)
Condition
Adult B Acute Lymphoblastic Leukemia
Intervention
Cytarabine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-06